The disruption of SRC-3 expression in Tregs leads to a “complete lifetime eradication” of tumors in aggressive syngeneic breast cancer mouse models because deletion of SRC-3 alters the expression of a wide range of key genes involved in efferent and afferent Treg signaling. Here, NCOA3 is linked to breast carcinoma.